InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,144.80
(
0.98%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.47
(
0.36%
)
Bitcoin
64,208.03
(
-0.43%
)
Post# of 38376
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

JokersWild12

Send PM Follow Ignore
Followers 10
Posts 529
Boards Moderated 0
Alias Born 12/15/2011

JokersWild12

Re: ronrooster post# 38116

Friday, 06/02/2017 12:41:02 AM

Friday, June 02, 2017 12:41:02 AM

Post# of 38376
Like the words forward progress referenced in this pr. ENTB and RGBP continue to show in recent pr's that there has been forward progress with their continued testing in identifying a pathway to small molecule drugs for treating cancer and autoimmune diseases through activation or inhibition of NR2F6. This is getting closer all of the time. The potential is there for both humans and canines. The company has stated previously that there was interest in the company before the most recent pr's showing that forward progress. That outside interest can only be increasing with the development. IMO. One of these days it will be just be announced that they are in talks with a buyer, or investors. ALL IMO. GL.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up